Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy.
Adolescent
Adult
Age Distribution
Age of Onset
Aged
Aged, 80 and over
Child
Child, Preschool
Cross-Sectional Studies
DNA, Mitochondrial
/ genetics
Databases, Factual
Female
Humans
Infant
Infant, Newborn
Internationality
Male
Middle Aged
Mitochondrial Diseases
/ epidemiology
Optic Atrophy, Hereditary, Leber
/ epidemiology
Point Mutation
Sex Distribution
Vision Disorders
/ epidemiology
Journal
Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
22
08
2019
revised:
08
11
2019
accepted:
15
11
2019
pubmed:
15
1
2020
medline:
20
9
2020
entrez:
15
1
2020
Statut:
ppublish
Résumé
To study the demographics of Leber's hereditary optic neuropathy (LHON) using a large international database of people affected by LHON. Cross-sectional study. One thousand five hundred seventeen people affected by LHON with a known pathogenic genetic mutation. Self-reported genetic and demographic data were collected. The data were de-identified and then analyzed. Leber's hereditary optic neuropathy mutation, gender, age at vision loss onset, and geographical region. The data showed that both females and males can experience symptom onset at any age. We found a 3:1 male-to-female ratio. Interestingly, at younger than 5 years and older than 45 years, the male-to-female ratio of those becoming affected was approximately 1:1. A dramatic peak in age at onset of vision loss was found among males between 14 and 26 years of age. Disease onset in females occurred across all age groups, without any comparable dramatic peak of onset age. This study found that 10% of individuals become affected with LHON after 50 years of age. According to the literature, we found that the m.11778, m.14484, and m.3460 mutations were the most common LHON point mutations in both males and females, with a similar age at onset distribution. This was the largest study of LHON demographics to date. It showed that women carrying an LHON mutation are at higher risk of losing vision than is generally expected. Unlike the traditional 5:1 male-to-female ratio commonly reported in the literature, we found a 3:1 male-to-female ratio. Earlier studies may have harbored an ascertainment bias of overemphasizing the confirmation of this being a disease of young men. However, our data suggest that LHON is a disease that affects both females and males of all ages. This should prompt physicians to conduct genetic testing for LHON in all patients who meet the clinical criteria, regardless of whether they fit the demographics traditionally associated with the disease. Counseling about LHON should be offered to all maternal bloodline relatives, females and males of all ages, because they are at risk of sudden-onset legal blindness.
Identifiants
pubmed: 31932089
pii: S0161-6420(19)32295-X
doi: 10.1016/j.ophtha.2019.11.014
pii:
doi:
Substances chimiques
DNA, Mitochondrial
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
679-688Informations de copyright
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.